CMS Rule Set to Stabilize Small Health Insurance Markets

Share this content:
CMS Rule Set to Stabilize Small Health Insurance Markets
CMS Rule Set to Stabilize Small Health Insurance Markets

TUESDAY, Feb. 21, 2017 (HealthDay News) -- The U.S. Centers for Medicare & Medicaid Services (CMS) has proposed a rule in relation to new reforms intended to stabilize individual and small group health insurance markets for 2018.

The rule proposes policy and operations changes designed to stabilize the Marketplace, including special enrollment period pre-enrollment verification, which would expand the pre-enrollment verification of eligibility to individuals who newly enroll through special enrollment periods. The change would help ensure that special enrollment periods are available for all who are eligible, and would require individuals to submit supporting documentation.

In addition, the rule proposes allowing issuers to collect premiums for prior unpaid coverage before enrolling a patient in the next year's plan, and making adjustments to provide greater flexibility for issuers to provide more coverage options for patients. The rule also proposes a revised timeline for the Qualified Health Plan certification and rate review process for 2018, which would provide issuers with additional time to implement proposed changes, and suggests shortening the annual open enrollment period for the individual market.

"This proposal will take steps to stabilize the Marketplace, provide more flexibility to states and insurers, and give patients access to more coverage options," Patrick Conway, M.D., of the CMS, said in a statement. "They will help protect Americans enrolled in the individual and small group health insurance markets while future reforms are being debated."

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »